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INTRODUCTION
Melanocortins are produced by posttranscriptional processing of
the proopiomelanocortin (POMC) precursor. In tetrapods,
melanocortins comprise three different melanocyte-stimulating
hormones (-, - and -MSH) and adrenocorticotropic hormone
[ACTH (Castro and Morrison, 1997]. Teleost fish lack -MSH and
the POMC gene encodes an extra MSH (-MSH) in elasmobranches
(Takahashi and Kawauchi et al., 2006). Melanocortin signalling is
mediated by binding to a family of specific G-protein-coupled
receptors (GPCR) that positively couple to adenylyl cyclase.
Similarly to the agonist system, the number of receptors diverges
in vertebrate species. Tetrapod species invariably have five
melanocortin receptors (MC1R–MC5R). However, zebrafish has
six MCRs, with two copies of MC5R, whereas pufferfish have only
four receptors with no MC3R and only one copy of MC5R (Logan
et al., 2003). MC2R is specific for ACTH whereas the four other
MCRs distinctively bind MSHs (reviewed by Schiöth et al., 2005).
Atypically, melanocortin signalling is not exclusively regulated by
binding of endogenous agonists, as naturally occurring antagonists,
agouti and agouti-related protein (AGRP), compete with
melanocortin peptides by binding to MCRs. Agouti protein is a
potent melanocortin antagonist at MC1R and MC4R. By contrast,
AGRP is potent in inhibiting melanocortin signalling at MC3R and
MC4R, but is not active at MC1R (Cone, 2006). Studies in
mammalian species have demonstrated that MC1R is mainly
involved in the control of skin pigmentation whereas MC2R
regulates adrenal corticosteroid synthesis and secretion. MC3R and
MC4R are mainly expressed in the central nervous system and
regulate energy balance. MC5R has a wide distribution in the brain
and peripheral tissues, but always shows low expression levels
(Schiöth et al., 2005; Cone, 2006). Deletion of the MC5R gene in
mice results in nearly total loss of 125I-NDP-MSH binding sites in
skeletal muscle and the Haderian, lachrymal and preputial glands,
indicating that MC5R represents the major MCR in these tissues.
MC5R knockout mice exhibit a severe dysfunction of exocrine
secretion, affecting hair follicle-associated sebaceous, Harderian,
lachrymal and preputial glands. The absence of MC5R expression
results in reduced hair lipid content, which provokes defects in water
repulsion, and reduced coat insulation against cold environments,
resulting in an impaired thermoregulatory function (Chen et al.,
1997).
Several studies have corroborated similar functions of fish
melanocortin receptors to those reported in mammalian systems.
Recent experiments have demonstrated the involvement of MC1R
in the colour patterns of fish (Gross et al., 2009), the participation
of MC2R in the regulation of cortisol secretion (Metz et al., 2005;
Aluru and Vijayan, 2008) and the contribution of MC4R to the
control of food intake (Cerdá-Reverter et al., 2003a; Sánchez et
al., 2009a). However, MC3R and MC5R functions remain elusive
in fish. Unlike in the mammalian system, MC5R is highly
expressed within the telencephalon and hypothalamus of goldfish
(Cerdá-Reverter et al., 2003b) and fugu (Klovins et al., 2004),
suggesting its involvement in the regulation of an array of
physiological functions. Despite the relative lack of knowledge
of the function of fish MC5R, a few reports have focused on the
characterization of this receptor (Ringholm et al., 2002; Cerdá-
Reverter et al., 2003b; Klovins et al., 2004). In this paper, we
report the molecular and pharmacological characterization of the
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SUMMARY
The melanocortin 5 receptor (MC5R) plays a key role in the regulation of exocrine secretion in mammalian species. This receptor
has also been characterized in some fish species but its function is unknown. We report the molecular and pharmacological
characterization, as well as the tissue expression pattern, of sea bass MC5R. Cloning of five active alleles showing different levels
of sensitivity to endogenous melanocortin and one non-functional allele demonstrate the allelic complexity of the MC5R locus.
The sea bass receptor was activated by all the melanocortins tested, with ACTH and desacetyl-MSH and -MSH showing the
lowest efficiency. The acetylation of the MSH isoforms seems to be critical for the effectiveness of the agonist. Agouti-related
protein had no effect on basal or agonist-stimulated activation of the receptor. SbMC5R was mainly expressed in the brain but
lower expression levels were found in several peripheral tissues, including liver. Progressive fasting did not induce up- or
downregulation of hypothalamic MC5R expression, suggesting that central MC5R is not involved in the regulation of food intake
in the sea bass. MTII, a sbMC5R agonist, stimulated hepatic lipolysis in vitro, measured as free fatty acid release into the culture
medium after melanocortin agonist exposure of liver fragments, suggesting that MC5R is involved in the regulation of hepatic lipid
metabolism. Taken together, the data suggest that different allelic combinations may confer differential sensitivity to endogenous
melanocortin in tissues where MC5R is expressed and, by extension, in hepatic lipid metabolism.
Key words: melanocyte-stimulating hormone (MSH), proopiomelanocortin (POMC), MC5R, phosphodiesterase inhibitor (IBMX).
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sea bass MC5R (sbMC5R). The results provide the first evidence
of the complex allelic composition of the MC5R locus, as well
as the existence of null alleles producing nonfunctional proteins
and differences in the MC5R isoforms as derived form their
sensitivity to endogenous melanocortin agonists. In addition, our
data provide the first evidence of the involvement of fish MC5R
in the control of hepatic lipid metabolism.
MATERIALS AND METHODS
Animals and reagents
Male and female sea bass (Dicentrarchus labrax L.) were kindly
supplied by Tinamenor (Santander, Spain). Prior to the
experiments, the animals were maintained in 500l tanks supplied
with continuously aerated running sea water for 2months. Fish
were hand fed at 09:00h with a commercial diet (Proaqua
Nutrición, Palencia, Spain). Animals were anesthetized in 2-
phenoxy-ethanol (0.1%) for 2min before any manipulation and
killed by rapid decapitation. All experiments were carried out in
accordance with the principles published in the European animal
directive (86/609/CEE) concerning the protection of experimental
animals. Melanocortin peptides were from Bachem (Germany).
Zebrafish agouti-related protein (zfAGRP), was kindly donated
by Dr Millhauser from Department of Chemistry, University of
California, Santa Cruz, USA (Sánchez et al., 2009a). Unless
otherwise indicated, all reagents were purchased from Sigma (St
Louis, MO, USA).
Molecular cloning of sea bass MC5R
Genomic DNA isolated from blood was used as template for
touchdown PCR reactions with Taq DNA polymerase (Invitrogen,
Carlsbad, CA, USA) and degenerate primers designed against
conserved regions of the known MCR sequences. The 5 primer
(MCR3Fw2) was a 20-mer with the sequence: 5-
TACCACAGYATCRTGACMGT-3. The 3 primer (RevFish) had
the sequence 5-TSAGVGTGATGGCKCCCTT-3 (Fig.1). PCR
products of about 274base pair (bp) were isolated from low melting
point (LMP) Nusieve GTG agarose gel (FMC) ligated into pGEM-
T easy vector (Promega, Madison, WI, USA) and subsequently
transformed into XLI-Blue E. coli. One clone that contained an insert
of the expected size was sequenced. The 3 extreme was resolved
by 3 RACE PCR. Specific primers for RACE-PCR were
sbMC5R_3RACE_1 (5-GACAGTGAAGAGAGCCG-3) and
sbMC5R_RACE_2 (5-TGCTATGCTGCTCATCATG-3). A
fragment of about 678bp was subcloned into pGEM-T easy vector
and sequenced. The 5 region was cloned by nested PCR using a
cDNA library as template (kindly supplied by Dr Bernardini form
the University of Insubria, Italy), sbMC5R-specific (MC5R_5
RACE_cDNA_synthesis: 5-ACTCCTGAAGGCATAGAT-3 and
MC5R-5WALKER2: 5-GAACATTGAGACCAGGCAGATGA -
TGACG-3) and universal PBSSK-vector primers. A fragment of
about 812bp was subcloned into pGEM-T easy vector and
sequenced. Finally the coding region was amplified using specific
primers (Hind-sbMC5R-Forward 5-TATAAGCTTATGAATG -
CATCAGATGATCAGT-3, Xho-sbMC5R-Reverse 5-TTACT -
CGAGTCATGTGGGCTTCTCCTCG-3 and brain cDNA,
synthesized from total RNA pooled from several animals, as
template. Fragments of about 990bp were subcloned into pGEM-
T easy vector and sequenced on both strands. The nucleotide
sequences of sbMC5Rs have been deposited in the EMBL
Nucleotide Sequence Database under accession numbers: P0:
FN429774, P1: FN429769, P2: FN429770, P5: FN429772, P8:
FN429773.
RT-PCR and Southern blot analysis
Total RNA was purified from fresh tissues (testis, ovary, intestine,
fat, liver, white and red muscle, spleen, head kidney, posterior
kidney, gill, dorsal skin, ventral skin, eye, heart, pituitary and brain)
and treated with RQ1-DNAse (Promega). Superscript II reverse
transcriptase (Invitrogen) was used for cDNA synthesis by priming
with oligo(dT)12-18 (Invitrogen). The cDNA was subsequently used
as template for touchdown PCR reactions with Taq DNA polymerase
(Invitrogen) and specific primers. The 5 primer was sbMC5R_3
RACE1 (5-GACAGTGAAGAGAGCCG-3) and the 3-primer
was MC5R_5RACE_cDNA (see above). Subsequently, PCR
fragments were separated on 1.2% agarose gel and transferred by
capillarity to Hybond-N nylon membrane (Amersham, Piscataway,
NJ, USA). Membranes were prehybridized for at least 3h in
hybridization solution (50% formamide, 6 SSPE, 0.5% SDS, 5
Denhardt’s solution and 10mgml–1 yeast tRNA type III; 1 SSPE
contained 150mmoll–1 NaCl, 1mmoll–1 EDTA, 9mmoll–1
NaH2PO4; pH7.4). Hybridization was carried out overnight in fresh
hybridization solution containing 0.5106c.p.m.ml–1 [-32P]dCTP
at 42°C. A probe containing the central region of the sbMC5R coding
region was used. Final washes were performed in 0.1 SSPE at
65°C. After 2h and 3days of exposure at –80°C, films were
developed and scanned. Touchdown PCR for 18S RNA was carried
out as an internal control for the reverse transcription step. Primer
sequences were 18S_Fw 5-GCATGCCGGAGTCTCGTT-3 and
5 18S_Rev 5-TGCATGGCCGTTCTTAGTTG-3.
Real-time quantitative PCR
To evaluate mRNA levels, total RNA from individual hypothalamus
or pituitary was treated with RQ1-DNAse. One microgram was used
as template for cDNA synthesis, which was primed with random
hexaprimers (Invitrogen). Two microlitres of cDNA (sbMC5R) or
diluted cDNA (18S RNA) and primers (70nmoll–1) were added to
7.5l of Sybr Green PCR master mix (ABgene, Thermo Scientific,
Madrid, Spain) and the volume was adjusted to 15l with water.
PCRs were carried out on an iCycler (Bio-Rad, Madrid, Spain).
Data were analyzed with the Ct (cycle threshold) method. As
internal control a fragment of the sea bass 18S RNA gene was
amplified, using primers 18S_Fw and 18S_Rev primers (see above).
Expression of 18S RNA gene was demonstrated to be stable after
fasting in previous studies (Sánchez et al., 2009a). Specific gene
primers were as follows: qPCR_MC5R_Fw1 (5-ATGAACACC -
ACAGA GG CTCA-3) and qPCR_MC5R_Rev1 (5-ATAGCA -
TCCTGTG GACGAGT3).
Cell culture and transfection
HEK cells were transfected using a modified calcium phosphate
transfection method (Chen and Okayama, 1987) and grown in
DMEM (Invitrogen) containing 10% foetal bovine serum
(Invitrogen), penicillin (100i.u.ml–1) and streptomycin (100gml–1)
in a humidified atmosphere of 5% CO2 at 37°C.
Galactosidase enzyme assay
Galactosidase enzyme assays were performed as previously
described (Sánchez et al., 2009a). Briefly, the medium was removed
and 50l of lysis buffer containing 250mmoll–1 Tris-HCl pH8 and
0.1% Triton X-100 were added. After one round of freezing
(–80°C) and thawing, 10l of the lysate were preserved for protein
assays. Phosphate saline buffer (40l) containing 0.5% BSA and
60l of substrate buffer (1mmoll–1 MgCl2, 10mmoll–1 KCl,
5mmoll–1 -mercaptoethanol and 200mgml–1 o-nitrophenyl--D-
galactopyranoside; ONPG) were added to the remaining lysate
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volume. The plate was incubated at 37°C for 5h and the absorbance
was read at 405nm in a 96-well plate reader (Tecan). Measurements
were normalized for the protein content, which was determined using
the BCA protein assay kit (Pierce, Rockford, IL, USA).
Pharmacological experiments
A HEK293 cell clone, stably expressing -galactosidase under the
control of vasoactive intestinal peptide promoter placed
downstream of tandem repeats of cAMP responsive elements
(CRE), was generated by co-transfection (50:1) of pCRE/-
galactosidase plasmid [kindly supplied by Dr R. Cone, Vanderbilt
University Medical Center (Chen et al., 1995)] and the
tgCMV/HyTK plasmid, which harbours a hygromycin resistance
gene (Wellbrock et al., 1998). Cells were selected in medium
containing 400gml–1 hygromycin B (Invitrogen). -galactosidase
activity was tested after incubating resistant clones in 96-well
plates (15,000 cells/well) with assay medium (DMEM medium +
0.1mgml–1 bovine serum albumin, BSA + 0.1mmoll–1
isobutylmethylxanthine (IBMX), containing 10–6moll–1 forskolin
for 6h. The clone showing highest response to forskolin (Clon-
Q) was selected for subsequent experiments (Sánchez et al.,
2009a). The full coding region of the sbMC5R was released from
pGEM-T easy vector (see above) and directionally subcloned into
pcDNA3 (Invitrogen). Double stable clones expressing -
galactosidase and sbMC5R were made by transfecting Clon-Q with
the latter construct using G-418 selection (800gml–1). Clones
were tested by incubating cells with MTII 10–6moll–1 in the assay
medium. The clone Q/P5-23 was selected for following
characterization of the activation profiles in response to several
melanocortins (monoacetyl-MSH or -MSH, diacetyl-MSH,
desacetyl-MSH or MSH, human ACTH, monkey -MSH,
zfAGRP, SHU9119 and HS024) in the absence of IBMX. The
effect of zfAGRP on basal sbMC5R activity was studied in both
the presence and absence of the phosphodiesterase (PDE) inhibitor.
To test the activity of the different sbMC5R polymorphisms,
Clon-Q was transiently transfected with sbMC5R-P0, -P1, -P2,
-P5 or -P8 and a construct carrying the luciferase gene under the
control of a constitutive promoter (Muriach et al., 2008). After
24h, cells were plated in 96-well plates (50,000 cells/well). Forty-
eight hours post-transfection, cells were stimulated with several
endogenous melanocortins, including -MSH, diacetyl-MSH,
desacetyl-MSH, human ACTH and monkey -MSH ranging
from 10–6 to 10–8moll–1, as before. Measurements were
normalized for the protein content, the luciferase activity and
forskolin-induced galactosidase activity. Receptor activation
assays were always performed in quadruplicate wells and repeated
at least three times independently.
Effects of progressive fasting on melanocortin system
To evaluate the effects of fasting on hypothalamic gene expression,
10 groups of 10 fish each [body mass117±1.54g] were
acclimatized for 1week to individual 500l aquaria and fed ad
libitum at 9:00h. After this acclimatization period, five groups were
fed the same ratio, and the other five were fasted. One fish from
each fed or fasted group was sampled at 12:00h (3h post-feeding
in the case of the fed groups) at 1, 4, 8 and 15 and 29days,
respectively. Anesthetized fish were weighed and blood samples
were obtained by puncture of the caudal vessels. Subsequently the
fish were decapitated and the whole hypothalamus dissected for
immediate total RNA extraction. RNA samples were kept at –80°C
in 75% ethanol until cDNA synthesis for quantitative PCRs (see
above).
Effects of melanocortin agonist on hepatic lipolysis
To evaluate the effects of melanocortin agonist on hepatic
lypolysis, the animals were sacrificed and their livers carefully
removed. Small liver slices (50–80mg) were dissected and
incubated in 1ml HB medium (136.9mmoll–1 NaCl, 5.4mmoll–1
KCl, 0.81nmoll–1 MgSO4, 0.44mmoll–1 KH2PO4, 0.33mmoll–1
Na2HPO4, 5mmoll–1 NaHCO3, pH7.6), containing 5mmoll–1
glucose, 1.5mmoll–1 CaCl2 and 2.5% fat-free BSA for 60min at
25°C. Subsequently, the medium was removed and slices were
incubated with 1ml of HBS containing 10–6moll–l MTII. After 2
and 4h at 25°C medium was removed for determination of non-
esterified fatty acids (NEFA) using commercial kits (WAKO
Diagnostics, Neuss, Germany), following the supplier’s
recommendations. Liver slices were mechanically homogenized
for protein determination using the BCA protein assay kit (Pierce).
Subsequently, dose–response studies were done by incubating liver
slices with MTII in HB ranging from 10–6 to 10–9moll–1 for 4h.
Experiments were always performed in quadruplicate wells and
repeated at least three times independently.
Data analysis and statistics
Sequence comparisons and alignments were performed using
ClustalX. A phylogenetic tree was derived using public domain
ClustalX, which uses the Neighbour-Joining method on a matrix of
distances. The position of transmembrane domains was drawn
according to secondary structure prediction for human MC1R
(Haitina et al., 2007a). Receptor activation data were fitted using
SigmaPlot software. Differences in the sensitivity of sbMC5R
isoforms and sbMC5R expression levels were analyzed by one-way
ANOVA (P<0.05).
RESULTS
Molecular cloning of sbMC5R
By means of RT-PCR and using degenerate primers designed against
conserved regions of fish melanocortin receptor sequences, we
cloned a 274bp fragment showing high identity with the MC5R
sequences reported in other vertebrate species. The 5 and 3 regions
were resolved by regular PCR and 3 RACE PCR using a cDNA
library or brain cDNA as templates, respectively. The full-length
cDNA sequence was amplified by PCR using specific primers and
brain cDNA as template. Fig.1 shows the full-length cDNA
sequence of isoform 1 of the sbMC5R (P1), which was sequenced
twice on both strands. The cloned fragment contains an open reading
frame of 1080bp that encodes a putative 360 amino acid protein
with seven putative hydrophobic transmembrane domains (TMDs;
Figs1, 2). Similar to other melanocortin receptors, the sbMC5R
orthologue has short extracellular (ECL) and intracellular (ICL)
loops and has cysteine residues at positions 266, 279 and 285 (sea
bass numbering), which are fully conserved in all melanocortin
receptors (Fig.2 and http://www.gpcr.org). The deduced amino acid
sequence shares 64–82% identity with other MC5R sequences but
less than 59% with other MCR sequences. The identity is unequally
distributed, and the N-terminal extracellular domain has the lowest
similarity to other MC5Rs, including pufferfish MC5R. More than
50% of the divergence between sea bass and pufferfish MC5R
orthologues resides within the N-terminal domain, encoding only
14% of the total protein length. A more detailed comparison among
cloned fish MC5R shows that the overall identity level of sea bass
receptor with other MC5Rs is highest (>96%) within TMD7 and
lowest in TMD4 (<68%). The overall identity ranged between 80%
and 92% within TMD1, TMD2, TMD3, TMD5 and TMD6. Unlike
other MC5Rs, the sea bass protein has an extended intracellular tail
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(ICL4). The deduced amino acid sequence has potential N-
glycosylation sites within the N-terminal domain at positions 2, 17
and 28 (Fig.1). Sea bass MC5R also has a PMY motif in the first
ICL, which is conserved in most melanocortin receptors. The motif
DRY of TM3, a consensus motif of the class A rodopsin-like G
protein-coupled receptor, is also present. Consensus recognition sites
for protein kinase C (PKC) and cAMP- and cGMP-dependent
protein kinases within ICLs were found at positions 170 in ICL2,
248 in ICL3 and 320, 329 and 339 within ICL3 (Fig.1), suggesting
regulation by phosphorylation.
We found five receptor isoforms (P0, P1, P2, P5, P8), which were
sequenced twice on both strands, involving nine single nucleotide
polymorphisms (SNPs) at positions 42, 71, 274, 446, 652, 829, 866,
937 and 1074 (Fig.1). These SNPs result in eight putative amino
acid substitutions at positions 14, 24 (ECL1), 92 (TM2), 149 (TM4),
218 (TM6), 277 (ECL4), 289 (TM6) and 313 (ICL4, Fig.3). Other
than P0, P5 was the most divergent isoform, exhibiting four unique
substitutions within the ECL1, TMD5, TMD7, ICL4. By contrast,
P1 and P2 were found to have unique substitution within TMD2
and ECL4, respectively, whereas P8 had no unique substitutions.
There were no coincident substitutions between P2 and P5, different
from those observed in P1 and P8. The isoform P0 had an extra
thymine base at position 551/552 (Fig.1), involving a change in the
reading frame and resulting in a divergent and shortened C-terminal
region of the receptor (Fig.3). Analysis of the receptor structure
predicts the disruption of the transmembrane structure within the
C-terminal region.
Peripheral and central distribution of sbMC5R mRNA
RT-PCR using specific primers targeting sequences within TMD4
and TMD7 of sbMC5R resulted in a band of the expected size of
about 436bp (Fig.4A). The identity of the band was confirmed by
Southern blot hybridization with a sbMC5R probe including the full
coding region. sbMC5R mRNA was easily detected in the retina,
brain, liver, spleen, gill, testis and dorsal skin. Low levels were also
distinguishable in the pituitary, posterior kidney, fat tissue, intestine,
red muscle and ovary (Fig.3A). Finally residual levels were detected
in the head kidney, dorsal skin, white muscle and heart. Inverse
transcriptions and cDNA quality were corroborated by PCR
amplification of 18S RNA that yielded bands of expected size in
all reactions (Fig.4B).
Activation by melanocortin analogues
For pharmacological and functional characterization of sbMC5R,
the coding region of the P5 isoform, was ligated into pcDNA3 and
stably expressed in HEK293 cells already producing -galactosidase
under the control of cAMP responsive elements. SbMC5R was
positively coupled to the cAMP-signalling pathway in response to
all melanocortins tested (Fig.5). NDP-MSH was the most potent
agonist, activating the receptor with a half-maximal effective
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                                                 I                                S
      M  N  A   S  D  Q  S   S  Y  Q   E  E  V   M  L  G  N   S  T  W   A  Y  Y   Y  Y  H  Q  27
   1 ATGAATGCAT CAGATCAGTC CTCCTACCAA GAGGAGGTGA TGCTGGGTAA CTCCACCTGG GCTTATTACT ACTATCACCA
                                                  A(P5)                           C(P5;P8)
       N  Y  T   L  S  P   P  L  L  P   D  K  T   S  T  S   K  P  A  A   C  E  Q   V  H  I    53
  81 AAACTACACC CTGTCCCCTC CACTGCTACC AGACAAGACC AGCACTTCCA AACCTGCAGC ATGCGAGCAG GTCCACATCG
     A  I  E  V   F  L  I   L  G  I   I  S  L  L   E  N  I   L  V  I   T  A  I  V   K  N  K   80
 161 CTATAGAGGT CTTTCTGATC CTGGGTATCA TCTCCCTGCT GGAGAACATC CTGGTCATCA CAGCCATAGT AAAGAACAAG
                                          S
      N  L  H   S  P  M  Y   F  F  V   C  N  L   A  V  A  D   M  L  V   S  V  S   N  A  W  E 107
 241 AACCTGCACT CACCCATGTA CTTCTTCGTT TGCAATCTGG CAGTAGCCGA CATGCTGGTG AGCGTGTCCA ACGCCTGGGA
                                          G(P2;P5;P8)
       T  I  I   I  Y  L   L  N  N  R   Q  L  V   V  E  D   H  F  I  R   Q  M  D   N  V  F   133
 321 GACCATCATT ATTTACCTCC TCAACAACAG GCAGCTGGTT GTGGAGGACC ACTTCATCAG GCAGATGGAC AACGTGTTTG
                                                      P
     D  S  M  I   C  I  S   V  V  A   S  M  C  S   L  L  A   I  A  V   D  R  Y  V   T  I  F  160
 401 ACTCCATGAT CTGCATCTCT GTGGTTGCGT CCATGTGTAG CCTGCTGGCC ATCGCTGTGG ATAGGTACGT CACTATCTTC
                                                       C(P0)
      Y  A  L   R  Y  H  N   I  M  T   V  K  R   A  G  F  I   I  A  G   I  W  T   F  C  T  G 187
 481 TATGCGCTGA GGTATCACAA CATCATGACA GTGAAGAGAG CCGGCTTCAT CATCGCGGGA ATCTGGACCT TCTGCACGGG
                                                                                  *(extra T;P0)
       C  G  I   V  F  I   I  Y  S  D   T  T  P   V  I  I   C  L  V  S   M  F  F   A  M  L   213
 561 CTGCGGGATC GTCTTCATCA TCTACTCAGA CACCACCCCC GTCATCATCT GCCTGGTCTC AATGTTCTTT GCTATGCTGC
                  T
     L  I  M  A   S  L  Y   S  H  M   F  M  L  A   R  S  H   V  K  R   I  A  A  L   P  G  Y  240
 641 TCATCATGGC CTCCCTCTAC AGCCACATGT TCATGCTGGC GCGCTCGCAC GTCAAGCGCA TCGCCGCCCT GCCTGGCTAC
                 A(P5)
      N  S  I   H  Q  R  A   S  M  K   G  A  I   T  L  T  I   L  L  G   I  F  I   V  C  W  A 267
 721 AACTCCATCC ACCAGCGGGC CAGCATGAAG GGGGCCATCA CGCTGACCAT CCTGCTGGGG ATCTTCATCG TCTGCTGGGC
                                    V                                       T
       P  F  F   L  H  L   I  L  M  I   S  C  P   R  N  L   Y  C  V  C   F  M  S   H  F  N   293
 801 GCCCTTCTTC CTCCACCTGA TCCTGATGAT CTCCTGTCCG CGGAACCTCT ACTGCGTGTG CTTCATGTCC CACTTCAACA
                                   G(P2)                                    C(P5)
                                                                   G
     M  Y  L  I   L  I  M   C  N  S   V  I  D  P   L  I  Y   A  F  R   S  Q  E  M   R  K  T  320
 881 TGTACCTTAT CCTCATCATG TGCAACTCTG TGATTGACCC GCTCATCTAT GCCTTCAGGA GTCAGGAGAT GAGGAAGACT
                                                                  G(P5)
      F  K  E   I  I  C  C   Y  S  L   R  N  A   C  T  N  I   C  T  L   T  E  T   A  A  K  T 347
 961 TTTAAGGAGA TCATCTGCTG TTACAGCCTG AGAAACGCCT GCACCAACAT CTGCACCCTG ACAGAAACAG CAGCAAAAAC
       L  N  V   I  R  H   R  A  E  E   K  P  T                                              360
1041 ACTGAACGTG ATACGACATC GGGCCGAGGA GAAGCCCACA
                                         A(P2)
Fig.1. Nucleotide and deduced amino acid
sequence of sea bass melanocortin
receptor 5 (sbMC5R), P1 isoform.
Nucleotide and amino acid sequence
numbers are indicated on the left and right
sides, respectively. Position of different
polymorphisms and the corresponding
isoform are shown. Underlining indicates
putative transmembrane domains (Haitina
et al., 2007a). Boxes indicate putative
N-linked glycosylation sites; circles,
possible phosphorylation sites. Sea bass
MC5R_P1 sequence accession number is
FN429769.
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concentration (EC50) of 0.133nmoll–1. Activation by MTII and
SHU9119 showed an EC50 of 1.82nmoll–1, and 3.72nmoll–1,
respectively, whereas the effective concentration increased to
22.4nmoll–1 and 93.3nmoll–1, and 107nmoll–1 and 167nmoll–1
when cells were incubated with HS024, diacetyl-MSH, -MSH and
monkey -MSH, respectively. Sigmoid curves cannot be fitted for
desacetyl-MSH and ACTH since receptor was only activated by the
highest melanocortin concentrations (1moll–1).
SbMC5R was also activated by the non-selective melanocortin
agonist MTII (EC505.69nmoll–1). When a phosphodiesterase
inhibitor (IBMX) was added to the medium, the response of the
reporter gene to incubation with MTII increased
(EC500.167nmoll–1). The incubation of sbMC5R-expressing HEK
cells with AGRP, in the presence or absence of IBMX, had no effects
on receptor activation. Under these conditions, AGRP had no effect
on MTII-stimulated cAMP production (EC5017nmoll–1 and
                                      *        20         *        40         *        60         *        80         *       100         *       120
Homo sapiens MC5R           :-MNSSFHLHFLDLNLNATEG--------NLSGPN-------VKNKSSPCEDMG  IAVEVFLTLGVISLLENILVIGA  IVKNKNLHSPMY  FFVCSLAVADMLVSMSSAWETITI  YLLNNKHL:104
Takifugu rubripes MC5R      :-..T.HRSSDPQEGIMGNSTWNPLSYQP.FTLSPPLLP----.T.TAA..QLH..I.......I..........M...........................V.N.S...I.......Q.:115
Dicentrarchus labrax MC5R P1:-..A.DQSSYQEEVMLGNSTWAYYYYHQ.YTLSPPLLPDKTSTS.PAA..QVH..I....I..I..........T.................N.........V.N.....I......RQ.:119
Cyprinus carpio MC5RII      :-..T.-EATLSLWAIYVNS--SPVSYLL.VTETP-------SHA.PKA..QLN..T....I..IV.........C...........................V.N.....I....T.RQ.:109
Cyprinus carpio MC5RI       :-..T.-EATLSLWAIYVNS--SPVSYLL.VTETP-------SHA.PKA..QLN..T....I..IV.........C...........................V.N.....V....T.RQ.:109
Carassius auratus MC5R      :M..T.-EATLSLWAIS.NS--SPVLDLL.TTETP-------SHA.PKA..QLN..T....I..I..........C...........................V.N.....V....T.RQ.:110
Danio rerio MC5Ra           :--------------MHVNS--SPASYIL.ATETP-------SH..PKA..QLN..T....I..IV.........C...........................V.N.....V....T.RQ.: 97
Danio rerio MC5Rb           :-....EWPTLSPNLSLSQAN------LSDE.SRP-------KTSA.AA..QVH..P.......L..........L...........................V.N.....V.H..A.RS.:106
                                      *       140         *       160         *       180         *       200         *       220         *       240
Homo sapiens MC5R           :VIADA  FVRHIDNVFDSMICISVVASMCSLLA  IAVDRYVTIFYALRYHHIMTAR  RSGAIIAGIWAFCTGCGIVFIL  YSESTYVIL  CLISMFFAMLFLLVSLYIHMF  LLARTHVKRIAALP-:223
Takifugu rubripes MC5R      :IAE.HLI.QL.....................................N...V..A.C..G...T..........I..DT.P..I..VC......LIMA...S...M...S.........-:234
Dicentrarchus labrax MC5R P1:.VE.H.I.QM.....................................N...VK.A.F......T..........I..DT.P..I..V.......LIMA...S...M...S.........-:238
Cyprinus carpio MC5RII      :.VE.H.I.QM.....................................N...V..AAL..G...T..........I..DN.S..V..V....I..A.MA...S...M...S.........-:228
Cyprinus carpio MC5RI       :.VE.H.I.QM.....................................N...V..AAL..G...T..........I..DN.S..V..V....I..A.MA...S...M...S.........-:228
Carassius auratus MC5R      :.VE.H.I.QM.....................................N...V..AAF..G...T...S......I..DN.S..V..V....I..A.MA...S...M...S.........-:229
Danio rerio MC5Ra           :.VE.H.I.QM.....................................N...V..AAL..G...T..........I..DN.S..V..V....I..A.MA...S...M...S.........-:216
Danio rerio MC5Rb           :..E.H.I.QM......L......G..W....................N...V..A.IL.GS..T.S.S...I..I..DTKP.VV..VA......LMMA...S.......S....M....-:225
                                      *       260         *       280         *       300         *       320         *       340         *       360
Homo sapiens MC5R           :--GASS-ARQRTSM  QGAVTVTMLLGVFTVCWAPFFLHLTLM  LSCPQNLYCS  RFMSHFNMYLILIMCNSVMDPLIYAF  RSQEMRKTFKEIIC-CRGFRIACS----FPRRD----------:325
Takifugu rubripes MC5R      :--.SN.-IH..A..K..I.L.I...I.II.........I..I...R....MC.................I....................F-.YSL.NT..TICTL.GKY----------:340
Dicentrarchus labrax MC5R P1:--.YN.-IH..A..K..I.L.I...I.I..........I..I...R....VC.................I.....................-.YSL.N..TNICTLTETAAKTLNVIRHR:354
Cyprinus carpio MC5RII      :--.YN.-IH..A..KA...L.I...I.I..........I..I...R....MC.................I...............L.....-.YSL.NVFG----MS.------------:328
Cyprinus carpio MC5RI       :--.YN.-IH..A..KA...L.I...I.I..........I..I...R....MC.................I...............L.....-.YSL.NVFG----MS.------------:328
Carassius auratus MC5R      :--.YN.-IH..A..KA...L.I...I.I..........I..I...R....MC.................I...............L.....-.YSL.NVFG----MS.------------:329
Danio rerio MC5Ra           :--.YN.-IH..A..KA...L.I...I.I..........I..I...R....MC.................I...............L.....-.YSL.NVFG----MS.------------:316
Danio rerio MC5Rb           :--.YNANI...A..K....L.I...I.I..........I..I...R.I..VC.................I......L............V.-.E.L.SF.N----MVSKY----------:328
Homo sapiens MC5R           :------:  -
Takifugu rubripes MC5R      :------:  -
Dicentrarchus labrax MC5R P1:AEEKPT:360
Cyprinus carpio MC5RII      :------:  -
Cyprinus carpio MC5RI       :------:  -
Carassius auratus MC5R      :------:  -
Danio rerio MC5Ra           :------:  -
Danio rerio MC5Rb           :------:  -
Fig.2. Alignment of MC5R amino acid sequences. Sea bass MC5R sequence is in bold letters. Dots indicate amino acids identical to the top sequence.
Dashes indicate spaces introduced to improve alignment. Grey boxes show putative transmembrane domains (see Fig.1).
                   *        20         *        40         *        60         *        80         *       100       
MC5R_P1 : MNASDQSSYQEEVMLGNSTWAYYYYHQNYTLSPPLLPDKTSTSKPAACEQVHIAIEVFLILGIISLLENILVITAIVKNKNLHSPMYFFVCNLAVADMLV : 100 
MC5R_P2 : ...........................................................................................S........ : 100 
MC5R_P8 : .......................S...................................................................S........ : 100 
MC5R_P5 : .............I.........S...................................................................S........ : 100 
MC5R_P0 : .......................S...................................................................S........                     
 
                   *       120         *       140         *       160         *       180         *       200       
MC5R_P1 : SVSNAWETIIIYLLNNRQLVVEDHFIRQMDNVFDSMICISVVASMCSLLAIAVDRYVTIFYALRYHNIMTVKRAGFIIAGIWTFCTGCGIVFIIYSDTTP : 200 
MC5R_P2 : .................................................................................................... : 200 
MC5R_P8 : .................................................................................................... : 200 
MC5R_P5 : .................................................................................................... : 200 
MC5R_P0 : ................................................P...................................LH.LRDRLHHLLRHH. : 200               
                                                                                                                     
                   *       220         *       240         *       260         *       280         *       300       
MC5R_P1 : VIICLVSMFFAMLLIMASLYSHMFMLARSHVKRIAALPGYNSIHQRASMKGAITLTILLGIFIVCWAPFFLHLILMISCPRNLYCVCFMSHFNMYLILIM : 300 
MC5R_P2 : ............................................................................V....................... : 300 
MC5R_P8 : .................................................................................................... : 300 
MC5R_P5 : .................T......................................................................T........... : 300 
MC5R_P0 : RHHLPGLNVLCYAAHHGLPLQPHVHAGALARQAHRRPAWLQLHPPAGQHEGGHHADHPAGDLHRLLGALLPPPDPDDLLSAEPLLRVLHVPLQHVPYPHH : 300               
                                                                             
                   *       320         *       340         *       360       
MC5R_P1 : CNSVIDPLIYAFRSQEMRKTFKEIICCYSLRNACTNICTLTETAAKTLNVIRHRAEEKPT : 360  
MC5R_P2 : ............................................................ : 360   
MC5R_P8 : ............................................................ : 360 
MC5R_P5 : ............G............................................... : 360 
MC5R_P0 : VQLCD------------------------------------------------------- : 305       
 
              
MC5R_P0 
   MC5R_P1
Fig.3. Alignment of sbMC5R isoforms. Dots indicate amino acids identical to the top sequence. Amino acid sequence numbers are indicated on the right
side. Underlined amino acids indicate putative transmembrane domains (see Fig.1). Amino acids that only change in one sequence are represented in red,
whereas amino acids present in at least two sequences are shown in green. Inset shows sequencing chromatograms comparing DNA sequences of
isoforms P0 and P1. Note the extra thymine base in the P0 sequence, leading to a shift in the reading frame that results in a shortened and divergent C-
terminal region in the P0 isoform. Sea bass MC5R sequence accession numbers: P0: FN429774, P1: FN429769, P2: FN429770, P5: FN429772, P8:
FN429773.
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0.15nmoll–1, in the absence or presence of IBMX, respectively;
Fig.6).
Subsequently, we used HEK293 cells stably expressing a
galactosidase reporter gene to transiently transfect the different
sbMC5R isoforms (P0, P1, P2, P5, P8). The isoform P0 never
responded to any melanocortin peptide, whereas the binding of
endogenous melanocortin to the P1-P8 isoforms differentially
activated the galactosidase gene transcription. Isoforms P1 and P8
activated the reporter gene more efficiently than P2 and P5 when
incubated with ACTH, -MSH, -MSH and desacetyl-MSH, but
not with diacetyl-MSH (Fig.7).
Effects of fasting on sbMC5R expression
Quantitative PCR did not yield significant differences in
hypothalamic MC5R mRNA expression levels when fed and fasted
animals were compared after 1, 4, 8, 15 and 29 days of fasting (data
not shown).
Effects of melanocortin agonist on hepatic lipolysis
The incubation of liver slices with 10–6moll–1 MTII in HBS
resulted in a significant increase in total NEFA concentration in the
culture medium after 4h but not after 2h (Fig.8A). Only the highest
MTII concentrations significantly stimulated NEFA production in
vitro (Fig.8B).
DISCUSSION
The present study provides evidence of the allelic complexity of
the MC5R locus in sea bass and substantiates the presence of several
isoforms that exhibit different sensitivity to endogenous
melanocortin agonist. We also describe a non-functional isoform
of the sbMC5R with a divergent C-terminal region. Tissue
expression patterns revealed high expression levels in the central
nervous system with lower levels in several peripheral tissues
including liver. The function of MC5R in fish is unknown; however,
we demonstrate that MTII, a potent agonist of the sbMC5R,
E. Sánchez, V. C. Rubio, J. M. Cerdá-Reverter
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Fig.4. Distribution of sea bass MCR5 mRNA expression in different tissues,
as revealed by RT-PCR followed by Southern blot hybridization.
(A)Phosphoimaging screen showing a Southern blot analysis of the sea
bass receptor following RT-PCR, and (B) ethidium bromide-stained agarose
gel of RT-PCR amplifications of sea bass 18S RNA.
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Fig.5. Effects of synthetic (HS024, MTII, NDP-MSH, SHU9119), and
endogenous (ACTH, -MSH, -MSH, diacetyl-MSH and desacetyl-MSH)
melanocortin on galactosidase activity in HEK293 cells stably expressing
both sbMC5R-P5 and a cAMP-responsive -galactosidase reporter gene in
the absence of phosphodiesterase inhibitors (IBMX). Data were normalized
to protein levels and expressed as percentage of the basal levels.
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Fig.6. Effects of inverse agonist, agouti-related protein (AGRP), on basal
and MTII-stimulated galactosidase activity in HEK293 cells stably
expressing both sbMC5R-P5 and a cAMP-responsive -galactosidase
reporter gene in the presence or absence of phosphodiesterase inhibitors
(IBMX). Data were normalized to protein levels and expressed as
percentage of the basal levels.
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stimulates hepatic lipolysis, suggesting that the different MC5R
isoforms could play a role in hepatic metabolism.
Amino acid sequence comparisons show that the cloned receptor
in sea bass displays high identity with other cloned MC5Rs. Most
of the divergence in sbMC5R is within the N-terminal extracellular
domain. However, this receptor domain is not likely to be
functionally important for agonist binding, since it has been
demonstrated that 28 amino acids from the N-terminal extracellular
domain can be deleted, including all potential N-glycosylation sites,
without affecting ligand binding to human MC5R (Schiöth et al.,
1997). Similarly, ECLs of the mouse MC5R do not participate in
the ligand binding of melanocortin agonist (Schiöth et al., 1998).
Accordingly, sbMC5R has low sequence identity with other MC5Rs
within the ECLs but, in contrast, shares a high sequence identity
with other MC5Rs within the TMDs. Point mutagenesis of human
MC1R suggests that important determinants for agonist binding lie
within TMD2, TMD3 and TMD7 (Yang et al., 1997), where
sbMC5R has higher than 82%, 83% and 92% sequence identity,
respectively, when compared with other MC5Rs.
To our knowledge, the MC5R locus, unlike MC1R, has not been
reported to be highly polymorphic in species in which the receptor
has been cloned (García-Borrón et al., 2005; Sanchez et al., 2009b).
However, we found nine DNA polymorphisms during the cloning
process. Eight mutations resulted in substitution of a different amino
acid and only one was a silent mutation. These polymorphisms
were incorporated into five different isoforms. Furthermore the P0
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Fig.7. Effects of endogenous (ACTH, -MSH, -MSH, diacetyl-MSH and desacetyl-MSH) melanocortin on galactosidase activity in HEK293 cells transiently
expressing different sbMC5R isoforms and the luciferase gene under the control of a constitutive promoter and stably expressing a cAMP-responsive -
galactosidase reporter gene. Experiments were done in the absence of phosphodiesterase inhibitors (IBMX). Data were normalized to protein levels,
luciferase activity and forskolin-induced galactosidase activity and expressed as percentage of the common basal levels. Asterisks indicate differences from
the basal level of that compound, after one-way ANOVA. Different letters indicate differences between isoforms at the specified hormone concentration, after
one-way ANOVA (P<0.05).
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isoform had an extra thymine that induces a change in the reading
frame, resulting in a divergent and shortened C-terminal region.
We initially selected the P5 isoform for pharmacological
characterization of the sbMC5R. Activation experiments
demonstrated that sbMC5R is activated by all melanocortin
mimetics. NDP-MSH, MTII and SHU9119, antagonists of sbMC4R
(Sánchez et al., 2009a), were the most potent agonists of the
sbMC5R with ED50s within the nanomolar range. Similarly, NDP-
MSH was also the most potent agonist of zebrafish (Ringholm et
al., 2002) and pufferfish MC5Rs (Klovins et al., 2004). Both
diacetyl-MSH and -MSH similarly stimulated cAMP-dependent
galactosidase activity but desacetyl-MSH-induced activation was
less efficient. Therefore, acetylation seems to be critical for
sbMC5R activation but not the level of acetylation since monoacetyl
(-MSH) and diacetyl-MSH were equipotent when activating the
receptor. All three MSH isoforms have been described in fish
pituitary (Dores et al., 1993) and the regulation of MSH acetylation
seems to be an important mechanism for background adaptation
and pigment patterns (Arends et al., 2000; Kobayashi et al., 2009).
SbMC5R was weakly activated by incubation with human ACTH
and -MSH. Experiments in trout demonstrated that MC5R affinity
for human ACTH (1-24) was higher than that observed for -MSH
and -MSH, both exhibiting equipotent binding capacities on trout
MC5R (Haitina et al., 2004). Our data suggest that sbMC5R is not
specific for ACTH or -MSH, although no definitive conclusions
can be drawn since we used human and monkey peptides,
respectively. Studies in lamprey have also demonstrated that the
cloned MCR subtype exhibits higher affinity to the lamprey ACTH
than to the MSH-A suggesting that ACTH is the ancestral ligand
(Haitina et al., 2007b).
Previous experiments in our laboratory demonstrated that
zebrafish AGRP (zfAGRP) is able to decrease the basal activity of
both sbMC4R and sbMC1R when incubated with a
phosphodiesterase inhibitor (IBMX), as occurs with an inverse
agonist, and decrease the effects of the melanocortin agonists on
the sbMC4R activation (Sánchez et al., 2009a; Sánchez et al.,
2009b), as occurs with an endogenous antagonist. We further
demonstrate here that this effect is specific for sbMC1R and
sbMC4R, since zfAGRP had no effect on basal sbMC5R activity
in the absence or presence of phosphodiesterase inhibitors. In
addition, our data corroborate the role of the phosphodiesterase
system in the AGRP inverse agonism. As expected, the addition of
IBMX decreased ED50 values of agonist-induced galactosidase
activity, thus increasing the sensitivity of the assay. In addition,
AGRP could not decrease the MTII-induced activation of the
sbMC5R as a competitive antagonist does. When we further studied
the activation of the different sbMC5R isoforms by the endogenous
melanocortin agonist, the P0 isoform, which has a shortened and
highly divergent C-terminal region, was ineffective in mediating
the cAMP-induced galactosidase activity upon exposure to natural
ligands. However, from our data it is not possible to discriminate
whether the binding properties of the receptor or its coupling to G-
proteins were disrupted. However, they strongly suggest that P0 is
a non-functional receptor isoform. The P1 and P8 isoforms displayed
higher sensitivity to endogenous melanocortins than the P2 and P5
isoforms, suggesting that specific MC5R allelic combinations may
confer differential sensitivity to endogenous melanocortin. It is
difficult to derive any conclusions concerning any structure–activity
relationship among active isoforms since no common substitution
patterns between P2/P5 and P1/P8 were found.
MC5R has different expression patterns in different vertebrate
lineages. As in mammalian species, sbMC5R was expressed in a
variety of peripheral tissues (Chen et al., 1997). Although no
quantitative experiments were carried out, sbMC5R mRNA levels
in the CNS seem to be higher than in the peripheral tissues. High
expression levels in the brain were also reported in other fish species
including zebrafish (Ringholm et al., 2002), goldfish (Cerdá-
Reverter et al., 2003b), pufferfish (Klovins et al., 2004), trout
(Haitina et al., 2004) and carp (Metz et al., 2005). The CNS
expression of MC5R has also been reported in human (Chhajlani
et al., 1993), rat (Griffon et al., 1994) and chicken (Takeuchi and
Takahashi, 1998) but very low levels were detected in mouse brain
(Gantz et al., 1994). The central function of MC5R is unknown but
experiments in rodent have demonstrated that central administration
of melanocortin stimulates aggression. By contrast, MC5R-deficient
mice exhibited reduced aggression and an elevated defence against
wild-type opponents (Morgan and Cone, 2006). The high expression
levels of MC5R in fish brain suggest implemented central functions
compared with mammalian systems. Our previous experiments in
goldfish demonstrated that the melanocortin system is involved in
the control of food intake. Central administration of melanocortin
analogues inhibit food intake (Cerdá-Reverter et al., 2003a; Cerdá-
Reverter et al., 2003b), whereas fasting dramatically increases
hypothalamic AGRP expression (Cerdá-Reverter and Peter, 2003).
Similar to sbMC4R (Sánchez et al., 2009a), progressive fasting did
not induce changes in hypothalamic sbMC5R expression, suggesting
that food deprivation cannot induce a downregulation of receptor
levels in the hypothalamic structures. The sbMC4R exhibits
constitutive activity and its actions are regulated by binding of the
inverse agonist AGRP (Sánchez et al., 2009a). The above model
cannot account for the MC5R-regulated hypothalamic pathways
since AGRP does not work as an inverse agonist or competitive
E. Sánchez, V. C. Rubio, J. M. Cerdá-Reverter
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Fig.8. Effects of melanocortin agonist MTII on hepatic lipolysis measured
as release of non-esterified fatty acids (NEFA) after hormonal treatment of
the culture medium. (A)Time course experiments using MTII at 10–6moll–1
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antagonist. POMC expression levels in the brain were also constant
after progressive fasting in sea bass (Sánchez et al., 2009a) and
goldfish (Cerdá-Reverter et al., 2003c). In the absence of modulation
of POMC expression levels by fasting and of any effect of AGRP
on basal or stimulated sbMC5R activity, an up- or downregulation
of sbMC5R expression after fasting would seem likely if the receptor
is involved in the control of food intake. Therefore, our data do not
support the involvement of this receptor in the control of food intake
in fish.
In mice, MC5R deficiency also causes severe dysfunction of the
exocrine glands by mis-regulation of sebaceous and preputial lipid
synthesis (Chen et al., 1997). We and others have found high levels
of MC5R mRNA in the fish skin and gills (Cerdá-Reverter et al.,
2003b; Metz et al., 2005) (present results), suggesting that MC5R
may be involved in the mucus production by globet cells present
in the gills and skin, and/or additional secretory skin cells (Shepard,
1994). RT-PCR experiments demonstrated expression of sbMC5R
in the ventral skin but no expression was found in the dorsal region.
Similar to many other vertebrates, sea bass have a specific pigment
pattern with darker colour in the dorsal area and a progressive
gradation towards white-yellow tones in the abdominal skin.
Differential MC5R expression in the ventral skin suggests a role in
pigment synthesis of the sea bass. Interestingly, sbMC5R was
expressed in tissues containing a high number of macrophages, i.e.
spleen, head kidney and gills, thus suggesting a role in the immune
system. Accordingly -MSH has been demonstrated to modulate
fish immune system (Harris and Bird, 2000). Moderate levels of
expression were also found in the liver and adipose tissue.
Involvement of the melanocortin system in the control of the fat
balance of fish is corroborated by the ‘cobalt’ phenotype of rainbow
trout. The absence of most of the pars intermedia of the pituitary,
where -MSH is synthesized, seems to be responsible for this
phenotype. This ‘cobalt’ trout is hyperphagic and exhibits an
enlarged liver and fat accumulation in the abdominal cavity,
reflecting the absence of -MSH lipolytic activity. This suggests
that the melanocortin system plays a role in the hepatic metabolism
by stimulating peripheral lipolytic activity, thus enhancing energy
expenditure. Our results further demonstrate that MTII, an agonist
of sbMC5R, is able to stimulate hepatic lipolysis in vitro, measured
as free fatty acid release into the culture medium after melanocortin
agonist exposure of liver fragments. This suggests that different
allelic composition results in differential hepatic sensibility to fasting
in sea bass. However, our experiments cannot fully exclude the
participation of other melanocortin receptors expressed in the sea
bass liver. Previous experiments have demonstrated the presence
of residual levels of MC1R and MC4R in the sea bass liver (Sánchez
et al., 2009a; Sánchez et al., 2009b). Our unpublished experiments
also demonstrated the expression of MC2R in the sea bass liver but
this receptor is specific for ACTH peptides in sea bass (M. J.
Agulleiro, E.S., V.C.R. and J.M.C.-R., unpublished data).
In summary, we report the molecular and pharmacological
characterization of sbMC5R, and point to its potential participation
in hepatic metabolism by promotion of lipolysis. sbMC5R is a
complex locus with at least five different alleles, resulting in five
isoforms. One of these isoforms was non-functional and the
remaining four exhibited different degrees of sensitivity to
melanocortin peptides. The results suggest that the different allelic
composition of the sbMC5R locus might result in different
phenotypes exhibiting differential activity in the hepatic metabolism.
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